Literature DB >> 1681040

Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.

W J Gullick1, C M Hughes, K Mellon, D E Neal, N R Lemoine.   

Abstract

Expression of the epidermal growth factor (EGF) receptor was evaluated by immunohistochemical staining of formalin-fixed, paraffin-embedded tumour tissues employing two antibodies raised to short synthetic peptides from the cytoplasmic domain of the molecule. Both antibodies gave concordant staining of a series of bladder cancers known to express or lack EGF receptors. There was no cross-reaction with the related c-erbB-2 protein, which was also over-expressed in some cases. Cancers with EGF receptor expression also expressed high levels of TGF-alpha, a receptor agonist.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681040     DOI: 10.1002/path.1711640403

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution.

Authors:  T Marchbank; R Chinery; A M Hanby; R Poulsom; G Elia; R J Playford
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Authors:  Kaoru Kiguchi; Takuya Kitamura; Tricia Moore; Mohammad Rumi; Hsiang-Chun Chang; Devon Treece; Lynnsie Ruffino; Kevin Connolly; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-03

3.  Gene expression profiles can predict panitumumab monotherapy responsiveness in human tumor xenograft models.

Authors:  Michael J Boedigheimer; Daniel J Freeman; Panteha Kiaei; Michael A Damore; Robert Radinsky
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

4.  Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-01

5.  Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.

Authors:  R J Hale; C H Buckley; W J Gullick; H Fox; J Williams; F L Wilcox
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

6.  Luminal and humoral influences on human rectal epithelial cytokinetics.

Authors:  M G Thomas
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

7.  Expression of the ERBB3 gene product in breast cancer.

Authors:  N R Lemoine; D M Barnes; D P Hollywood; C M Hughes; P Smith; E Dublin; S A Prigent; W J Gullick; H C Hurst
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

8.  Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

Authors:  P Lipponen; M Eskelinen
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

9.  Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.

Authors:  J K Mellon; S Cook; P Chambers; D E Neal
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.